NCT07443592 2026-03-02
LAL-2025
PETHEMA Foundation
Phase NA Not yet recruiting
Clinical Trials
10 trialsNCT07413146 2026-02-17
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial
Sun Yat-sen University
Phase NA Not yet recruiting
NCT07392970 2026-02-06
Motixafortide for MRD Sensitization in AML
Washington University School of Medicine
Phase 2 Not yet recruiting
NCT07301138 2025-12-24
BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients
Ruijin Hospital
Phase 2 Not yet recruiting
NCT07247201 2025-12-09
AlloNK1
Singapore General Hospital
Phase 1/2 Not yet recruiting
NCT07264010 2025-12-04
Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study
Nanfang Hospital, Southern Medical University
Phase 2/3 Not yet recruiting
NCT07257380 2025-12-02
MRD-ATLAS
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT06763302 2025-01-08
NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL
The Children's Hospital of Zhejiang University School of Medicine
Phase NA Not yet recruiting
NCT06090786 2024-04-10
Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Not yet recruiting
NCT06323148 2024-03-21
Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)
Fudan University
Phase 3 Not yet recruiting